z-logo
open-access-imgOpen Access
Microbiome and metabonomics study of quercetin for the treatment of atherosclerosis
Author(s) -
WU Dong-ning,
Le Luo Guan,
Yixin Jiang,
Su-Hua Ma,
Yanan Sun,
Hongtao Lei,
Weifeng Yang,
Qingfeng Wang
Publication year - 2019
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2019.12.04
Subject(s) - quercetin , medicine , pharmacology , biochemistry , biology , antioxidant
The molecular mechanism of quercetin in the prevention and treatment of AS has been widely reported. However, the microbial and metabolic characteristics of quercetin in AS treatment are still poorly understood. In this study, we aimed to explore the gut microbial and metabolic signatures of quercetin in AS treatment and conduct an integrative analysis on its biomechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here